Correlation Between Effector Therapeutics and NRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and NRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and NRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and NRx Pharmaceuticals, you can compare the effects of market volatilities on Effector Therapeutics and NRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of NRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and NRx Pharmaceuticals.
Diversification Opportunities for Effector Therapeutics and NRx Pharmaceuticals
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Effector and NRx is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and NRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRx Pharmaceuticals and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with NRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRx Pharmaceuticals has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and NRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Effector Therapeutics and NRx Pharmaceuticals
Given the investment horizon of 90 days Effector Therapeutics is expected to under-perform the NRx Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Effector Therapeutics is 5.56 times less risky than NRx Pharmaceuticals. The stock trades about -0.4 of its potential returns per unit of risk. The NRx Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 9.15 in NRx Pharmaceuticals on August 29, 2024 and sell it today you would lose (3.86) from holding NRx Pharmaceuticals or give up 42.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 22.02% |
| Values | Daily Returns |
Effector Therapeutics vs. NRx Pharmaceuticals
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| NRx Pharmaceuticals |
Effector Therapeutics and NRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and NRx Pharmaceuticals
The main advantage of trading using opposite Effector Therapeutics and NRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, NRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRx Pharmaceuticals will offset losses from the drop in NRx Pharmaceuticals' long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
| NRx Pharmaceuticals vs. NRX Pharmaceuticals | NRx Pharmaceuticals vs. Relief Therapeutics Holding | NRx Pharmaceuticals vs. Quantum Si incorporated | NRx Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |